Tuesday, 17 September 2019

Contract Manufacturing News

  • Kangstem, Orgenesis ink deal to develop cell therapies for atopic dermatitis

    Contract Manufacturing |  News | 0 Comment | 02 Oct, 2018

    Orgenesis, a manufacturer, service provider and developer of advanced cell therapies, has announced that Kangstem Biotech, a biotechnology company specializing in developing cell therapies ...Read more

  • AGC Biologics increases manufacturing capacity at Denmark

    Contract Manufacturing |  News | 0 Comment | 07 Sep, 2018

    AGC Biologics, a contract development and manufacturing organization specializing in the clinical and commercial manufacture of therapeutic proteins, announced that the company is increasin...Read more

  • CASI, Yiling Wanzhou team up to manufacture entecavir, cilostazol

    Contract Manufacturing |  News | 0 Comment | 25 Jun, 2018

    CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and delivery of high quality, cost-effective pharmaceutical products and innovative therapeutics to pati...Read more

  • ADC Bio suggests need of process innovation in early R&D phase

    Contract Manufacturing |  News | 0 Comment | 04 Jun, 2018

    ADC Biotechnology (ADC Bio) predicts that the next crucial phase of innovation to optimise and streamline production processes of ADCs will be designed at the clinical development...Read more

  • CMAB Biopharma raises funds worth $34 M

    Contract Manufacturing |  News | 0 Comment | 03 Apr, 2018

    China based CMAB Biopharma Inc. (CMAB), a full-service contract development and manufacturing organization (CDMO) providing process development and manufacturing services for biologic produ...Read more

  • The next frontier for CMOs

    Contract Manufacturing |  Opinion | 0 Comment | 18 Oct, 2017

    Long-term success of a pharmaceutical company is very closely linked with its ability to consistently research, patent, develop and market new drugs that can tackle as yet incurable...Read more

  • India and China have potential growth opportunities in CMOs space

    Contract Manufacturing |  Analysis | 0 Comment | 18 Oct, 2017

    According to Research and Markets, the global pharmaceutical contract manufacturing market to grow at a CAGR of 6.91% during the period 2016-2020. Contract manufacturing has potenti...Read more

  • German firm Evotec to pack up from India

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: Custom manufacturing German firm, Evotec is closing its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility to answer ...Read more

  • Ajinomoto acquires US firm Althea

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 07 Mar, 2013

    Singapore: Japan-headquartered Ajinomoto has entered into a definitive agreement to acquire Althea Technologies, a US-based provider of biopharmaceutical development and manufacturing servi...Read more

  • Pfizer testing unit to move to Singapore

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jun, 2012

    Pfizer's 20-person surveillance testing group located in Groton will be relocating to Singapore in 2013. The surveillance testing group is a part of the company's Scientific Laboratory Serv...Read more

  • India's Biological E to buy French Valneva's CMO unit

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2013

    Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit, which is dedicated to the ...Read more

  • ImaginAb, Singapore Radiopharmaceuticals sign agreement

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 08 Aug, 2012

    Singapore: ImaginAb, a developer of in vivo molecular imaging agents based on its proprietary antibody fragment platform, has signed a master service agreement (MSA) with Singapore Radiopha...Read more

  • WuXi PharmaTech board member steps down

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jul, 2014

    Singapore: Ms Ying Han, member of board of WuXi PharmaTech, has stepped down from the company. WuXi PharmaTech is China based global contract R&D services provider serving the pharmace...Read more

  • WuXi's subsidiary gets manufacturing nod in Japan

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2015

    Singapore: WuXi PharmaTech's small-molecule process development and manufacturing subsidiary Shanghai SynTheAll Pharmaceutical has received its first approval from the Japan PMDA for the ma...Read more

  • WuXi's API manufacturing passes FDA inspection

    Contract Manufacturing |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2014

    Singapore: China-based WuXiPharmaTech, pharmaceutical, biotechnology and medical device research and development outsourcing company, has succesfully passed the US Food and Drug Administrat...Read more

  • Biovest to spin off CMO business

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 16 Mar, 2016

    Singapore: Biovest International has decided to spin off its instrument and contract manufacturing offerings into a single wholly-owned subsidiary named Cell Culture Company. Cell Culture ...Read more

  • Marck products get approval in South Africa

    Contract Manufacturing |  News | By BioSpectrum Bureau  | 0 Comment | 09 Jan, 2013

    Mumbai: Marck Biosciences, an Indian manufacturer and marketer of sterile dosages and Blow-Fill-Seal (BFS) specialist, was granted approval by the South African Medicines Control Council fo...Read more

  • WuXi Life Science to acquire WuXi PharmaTech for around $3.3 bn

    Contract Manufacturing |  Company results | By BioSpectrum Bureau  | 0 Comment | 17 Aug, 2015

    Singapore: WuXi PharmaTech, research and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States,...Read more



Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls